Recommendations for the management of treatment and vaccination in inflammatory bowel disease patients complicated with coronavirus disease 2019
10.3760/cma.j.cn311367-20230106-00004
- VernacularTitle:炎症性肠病患者合并新型冠状病毒感染时治疗药物及疫苗接种管理建议
- Author:
Hong YANG
1
;
Liangru ZHU
;
Jie LIANG
;
Jiaming QIAN
;
Kaichun WU
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院消化内科，北京 100730
- Keywords:
Coronavirus infections;
Inflammatory bowel diseases;
Drugs;
Vaccine;
Management
- From:
Chinese Journal of Digestion
2023;43(2):84-88
- CountryChina
- Language:Chinese
-
Abstract:
Coronavirus disease 2019 (COVID-19) has become a worldwide pandemic. During the rapid spread time, it is a great challenge for patients with inflammatory bowel disease (IBD) who use immunosuppressive drugs from vaccination and drug application. This article is intended to supplement and revise the recommendations of the Inflammatory Bowel Disease Group of the Chinese Society of Gastroenterology in 2020 on the "Management of patients with inflammatory bowel disease during epidemic of novel coronavirus pneumonia", mainly including the treatment and vaccination of IBD patients complicated with COVID-19. It is expected to guide clinicians in drug use, vaccination of IBD patients at an appropriate time, also help patients getting through the epidemic period of COVID-19.
